HIGHCO : SHAREHOLDING AS 30/06/2017 INFORMATION

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
41
HIGHCO : SHAREHOLDING AS 30/06/2017

INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES

According to provisions of the article 223-16 of the Règlement Général AMF and of the article L.233-8 II of the French Code de commerce

Date of settlement of information Total number of shares Number of shares without voting rights (*) Number of voting rights for threshold calculation (**) Number of actual voting rights (exercisable at shareholders' meeting)
June 30, 2017 22 421 332 1 908 599 24 630 206 22 721 607
May 31, 2017 22 421 332 1 900 626 24 630 206 22 729 580
April 30, 2017 22 421 332 1 904 484 24 630 206 22 725 722
March 31, 2017 22 421 332 1 899 587 24 640 206 22 740 619
February 28, 2017 22 421 332 1 876 571 24 640 206 22 763 635
January 31, 2017 22 421 332 1 872 618 24 640 206 22 767 588
December 31, 2016 22 421 332 1 856 822 24 640 206 22 783 384

(*) exclusively consisting of treasury shares. (**) theoretical voting rights to calculate the threshold crossing including the voting right of treasury shares (article 223-11 of the Règlement Général AMF).

About HighCo

Since its creation, HighCo has placed innovation at the heart of its values, offering its clients - brands and retailers - Intelligent Marketing Solutions to influence shopper behaviour with the right deal, in the right place, at the right time and on the right channel. Listed in compartment C of Euronext Paris and eligible for the "long-only" DSS, HighCo has more than 700 employees and since 2010 has been included in the Gaia Index, a selection of 70 responsible Small and Mid Caps.

Your contacts

Cécile COLLINA-HUE                                                         Cynthia LERAT Managing Director                                                                Press Relations +33 1 77 75 65 06                                                                 +33 1 77 75 65 16 comfi@highco.com                                                              c.lerat@highco.com

 

Upcoming events

Publications take place after market close .

Q2 and H1 2017 Gross Profit: Wednesday, 19 July 2017 2017 Half-year Earnings: Wednesday, 30 August 2017 2017 Half-year Earnings conference call: Thursday, 31 August 2017 Q3 and 9-months 2017 Gross Profit: Wednesday, 18 October 2017 2017 Gross Profit: Wednesday, 24 January 2018

HighCo is a component stock of the indices CAC® Small (CACS), CAC® Mid&Small (CACMS) et CAC® All-Tradable (CACT). ISIN: FR0000054231 Reuters: HIGH.PA Bloomberg: HCO FP For further financial information and press releases, go to www.highco.com

This English translation is for the convenience of English-speaking readers. Consequently, the translation may not be relied upon to sustain any legal claim, nor should it be used as the basis of any legal opinion. HighCo expressly disclaims liability for any inaccuracy herein.

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...0ff663c939

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 487

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 513

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Laboratoires Pierre Fabre and XtalPi Unite for AI-Driven Drug Hunt

Updated Category News Views 46

An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 189

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Updated Category News Views 202

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 347

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

Updated Category News Views 56

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Continue Reading
AWS Boosts Agilix's AI Education in Sierra Leone

Updated Category News Views 62

Agilix Labs' Landmark Leap with AWS Just when you think you've got the grip on global education dynamics, a new wave hits your shores, this time courtesy of Agilix Labs and AWS. Agilix Labs snagged a grant from Amazon Web Services, carving a path that blends AI with educational equity in Sierra Leone. Now, if that doesn’t prick up investor ears or yank a few...

Continue Reading
Niagara Networks Boosts TLS 1.3 Decryption to 90+ Gbps

Updated Category News Views 95

In a digital era where encryption is racing ahead like a runaway train, Niagara Networks has stepped up with some serious muscle enhancements to their ePacketron platform. They're not just playing catch-up with the latest TLS 1.3 decryption capabilities; they're leading the charge with a robust over 90 Gbps performance—no small feat in today's encrypted traffic...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 345

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading

Top 5 Most Recently Viewed Articles

EssilorLuxottica Reports Share Capital and Voting Rights Update

Updated Category News Views 214

Overview of EssilorLuxottica's Share Capital EssilorLuxottica, a prominent global leader in eyewear design, manufacture, and distribution, provides a detailed disclosure of its outstanding share capital and voting rights as of a recent date. This information is essential for shareholders and market watchers to understand the company's governance and share structure. Share...

Continue Reading
WM Technology, Inc. Faces Class Action Lawsuit with SEC Fallout

Updated Category News Views 208

WM Technology, Inc. Faces Legal Challenges Recently, a class action lawsuit has arisen against WM Technology, Inc. (NASDAQ: MAPS), a pivotal player in the online cannabis marketplace. The Pomerantz Law Firm has initiated this legal action on behalf of affected investors. As the case unfolds, individuals who believe they have been impacted by the company's actions are...

Continue Reading
EVgo Targets 2026 for Profitable Future Amid Challenges

Updated Category News Views 554

EVgo Overview EVgo Inc. (NASDAQ: EVGO) has faced recent fluctuations in share price following the announcement of its fiscal third-quarter results. The company operates one of the largest public electric vehicle charging networks in the United States, and it has been navigating a challenging landscape in the EV sector. Financial Performance Analysis In its latest report,...

Continue Reading
CNX Resources Corporation Reveals Financial Updates and Call Schedule

Updated Category News Views 126

CNX Resources Corporation Financial Results Announcement CNX Resources Corporation (NYSE: CNX) is set to unveil its financial results for the fourth quarter of 2025. This important event will take place at 6:45 a.m. Eastern Time on an upcoming Thursday. During this announcement, CNX intends to release a concise press statement that will include essential documents linking...

Continue Reading
Nvidia's Revolutionary AI Dominance and Future Outlook

Updated Category News Views 193

Understanding AI and Nvidia's Impact Since the dawn of the internet, investors have seen many trends come and go, but few have been as impactful as the artificial intelligence (AI) revolution. This groundbreaking technology has sparked interest among both seasoned professionals and everyday investors, all eager to explore its immense potential. It’s estimated that AI...

Continue Reading